1922-P: Clinician Perspectives on Accessibility and Utilization of Continuous Glucose Monitors

Introduction and Objective: Continuous Glucose Monitor (CGM) technology is highly effective in improving glycemic control for individuals with type 1 diabetes and type 2 diabetes (T2D). However, CGM usage remains low among publicly insured, racial and ethnic minorities, and T2D patients. A better understanding of clinician perspectives on specific barriers may help uncover modifiable factors to CGM adoption. Methods: This qualitative study included semi-structured interviews with 18 clinicians from 17 health systems across the United States experienced in diabetes care management, including 9 adult primary care providers (PCPs) and 9 endocrinologists, selected through purposive sampling accounting for geography, practice type, and role, and supplemented by convenience and snowball sampling. Code mapping and axial coding were used for thematic analysis. Results: Four themes emerged from the interviews, with three themes identifying specific barriers to CGM use. The first theme, financial and insurance challenges, was the most commonly identified barrier by all clinicians, with patients in lower-income groups most affected. The second most prominent theme was educational gaps in clinician best practices for CGM use, followed by the third theme, structural barriers for supporting patients with T2D. In the fourth theme, clinicians highlighted interventions to address implementation and access challenges to improve CGM use, such as integrated care models, peer-led provider education, and clinic-based training protocols. Across all the themes, the educational gap theme had the greatest discrepancy between PCPs and endocrinologists, with 67% of PCPs reporting challenges in receiving standardized education and guidelines compared with 11% of endocrinologists. Conclusion: These findings highlight the need for system-level interventions, including standardized, guideline-driven CGM education for PCPs, clearer reimbursement and insurance coverage pathways, and expanded resources to support patient education and improve equitable CGM access. Disclosure S. Feinberg: None. A. Jhanjee: None. K. Ladin: None.